• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Synergy Research Group speeds ramp-up time for clinical trials

Synergy Research Group speeds ramp-up time for clinical trials

January 28, 2015
CenterWatch Staff

Synergy Research Group, a CRO based in Moscow, Russia, is addressing one of the most common roadblocks to clinical trial ramp-up by taking sales and business development out of the proposal and/or bid cycle. This is another step in Synergy’s commitment to offer quality, speed and lower cost to every sponsor.

Every prospective client or new project will be assigned an experienced study manager from the outset. The manager will bring in a team of experts on regulatory affairs, medical writing and others as needed to ensure that the full scope of the project is taken into consideration at the earliest possible moment, before a bid or proposal is submitted. Under this structure, the trial will be operational as soon as the sponsor approves the project.

“I’ve talked to a number of colleagues in the CRO industry and the delay that occurs during the handoff from business development to the beginning of the trial is a common concern,” said Igor Stefanov, CEO of Synergy Research Group. “Eliminating sales and business development and having the study manager involved from the outset will eliminate the ramp-up time and save sponsors’ time and administrative costs.”

The company has implemented a number of initiatives designed to increase transparency and offer the highest quality to sponsor companies. These initiatives include an interactive dashboard that gives a snapshot of the progress and health of all of the projects that Synergy currently is involved in.

Russia boasts large patient populations across high-demand therapeutic areas such as oncology, infectious disease and cardiovascular. Per-patient study costs are low in the region, despite having a large number of experienced researchers in multiple sites. Additionally, the per-patient spend on pharmaceuticals in the region is expected to more than double by 2016, growing to over four billion dollars annually.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing